A framework for assessing the risk of resistance for anti-malarials in development

Veure altres versions (1)

Resistance is a constant challenge for anti-infective drug development. Since they kill sensitive organisms, anti-infective agents are bound to exert an evolutionary pressure toward the emergence and spread of resistance mechanisms, if such resistance can arise by stochastic mutation events. New cla...

Descripció completa

Dades bibliogràfiques
Autors principals: Ding, Xavier C, Ubben, David, Wells, Timothy NC
Format: Online Article Text
Idioma:English
Publicat: BioMed Central 2012
Matèries:
Methodology
Accés en línia:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478971/
https://www.ncbi.nlm.nih.gov/pubmed/22913649
http://dx.doi.org/10.1186/1475-2875-11-292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478971/
https://www.ncbi.nlm.nih.gov/pubmed/22913649
http://dx.doi.org/10.1186/1475-2875-11-292

Ítems similars